Press Release

IntrinsiQ Announces IntelliScribe General Availability

IntelliDose Users Rave about Streamlined Workflow and Quality of Patient Care with Integrated Oncology-Specific E-Prescribe Solution

Waltham, Mass. (Jun 02, 2010) IntrinsiQ, provider of IntelliDose®, the leading chemotherapy management software, today announces the general availability of IntelliScribe™ – the first integrated e-prescribe solution for medical oncology.

Oncologists will now be able to manage complex chemotherapy drug orders – including oral and IV chemotherapy, antiemetics and pain medications – in one location, as part of the chemotherapy order. Streamlining practice efficiency, prescribers can conveniently submit electronic prescriptions while managing chemotherapy treatments. Every type of drug administered becomes part of the chemotherapy order: nothing is missed, contraindications are flagged, and the patient record is complete.

“Oncologists are prescribing an ever increasing number of oral medications. IntelliScribe gives them the tools to manage all of their prescribing needs in one location and create a unified chemotherapy record,” said Andrew Scott, director of product management, IntelliDose, a division of IntrinsiQ, LLC. “Integrating e-prescribe with chemotherapy regimen management creates a truly complete picture of the patient’s treatment history while enhancing efficiency, safety and ultimately the quality of patient care.”

Available now as a fully integrated component of IntelliDose, IntelliScribe is a full-featured e-prescribe solution. It can support all the e-prescribing needs of an entire practice, or for practices currently e-prescribing through an electronic medical record (EMR), IntelliScribe complements existing solutions to manage chemotherapy drug regimens.  

IntelliScribe incorporates RelayHealth’s eScript™ to electronically file prescription medications through the Surescripts prescribing network. This gives all clinicians in the oncology practice the ability to:

•    Submit prescriptions at any time while managing chemotherapy orders. Prescriptions may be submitted during chemotherapy order preparation prior to the office visit, when the patient arrives in the office, or after the patient is treated.

•    Conveniently and efficiently manage refill requests. Frequent and time-consuming phone messages are reduced as refill requests can be managed electronically from the IntelliDose desktop.

•    Access the complete prescribing history for patients. The chemotherapy record now gives prescribers the ability to see and use the information of prescribed medications from any provider, allowing a more efficient and safe way to manage both refills and renewals.

•    Create a comprehensive chemotherapy treatment record.  Manage both IV and oral therapies in a single system to allow users to review the entire treatment history in a unified patient record.

“Our patients have a tremendous amount of information to deal with while receiving their treatment,” said Thomas J. Jean, manager of Frisbie Memorial Hospital, Center for Cancer Care in Rochester, New Hampshire. “IntelliScribe is yet another way to improve a patient’s experience during a time of intense stress. The script is ordered, verified and sent before the patient leaves the office, and the prescriptions are ready when they reach the pharmacy. There are no surprises and everything’s correct.”

“We see as many as 400 patients a day,” said Kathy Ross, practice administrator of Little Rock Hematology Oncology Associates, one of the largest private oncology practices in Arkansas. “IntelliScribe helps us meet e-Prescribe and Meaningful Use requirements and – along with IntelliDose – significantly enhances our quality of care and practice efficiency.”

Developed by oncologists to automate even the most complex aspects of medical oncology, IntelliDose transforms the manual process of chemotherapy regimen calculations into electronically verified orders. It allows oncology practices to standardize cancer treatment pathways, and ensure the highest levels of patient safety and efficiency practice-wide. IntelliDose interfaces with leading EMR and hospital information systems, extending existing or planned technology investments to include cancer patient management.


About IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details from more than 750 oncologists, for nearly 20,000 patients, creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. IntelliDose ensures patient safety though automation and standards designed to meet the needs of a specific practice, saving staff time, maximizing reimbursement and reducing operating costs. For more information, please visit

Company Contact:

Media Contact:
Rachel Round
(617) 969-9192